期刊文献+

核酶对食管癌EC9706细胞端粒酶活性及凋亡的影响 被引量:1

Inhibitory effects of ribozyme on telomerase activity and apoptosis of esophageal carcinoma cell EC9706
下载PDF
导出
摘要 目的 :观察针对人端粒酶RNA模板区的核酶对食管癌细胞端粒酶活性和细胞凋亡的影响。方法 :利用脂质体Lipofectamine介导 ,将已构建好的带有端粒酶核酶基因的重组质粒pBBS2 12Rz及空载质粒pBBS2 12转染食管癌EC970 6细胞 ,采用TRAP ELISA法检测端粒酶活性 ,用倒置相差显微镜及流式细胞仪观察细胞生长和凋亡情况。结果 :重组质粒pBBS2 12Rz转染的食管癌EC970 6细胞的端粒酶活性明显下降 ,细胞生长速度明显变慢 ,凋亡加速。结论 :端粒酶核酶对食管癌细胞端粒酶活性和细胞生长有抑制作用 。 OBJECTIVE:To observe the effects of the ribozyme targeting the human telomerase RNA (hTR) on telomerase activity and cell apoptosis of esophageal carcinoma cell line EC9706.METHODS:The eucaryotic expression vector pBBS212Rz and vacant plasmid pBBS212 as a control were transfected respectively into the human esophageal carcinoma cell line EC9706 by lipofectamine.Telomerase activity of transfected cells was detected by TRAP-ELISA (Telomeric Repeat Amplification Protocol and enzyme-linked immunosorbant assay).Cell proliferation and apoptosis were detected by phase contrast microscope and flow cytometry.RESULTS:Telomerase activity of ribozyme transfected group decreased obviously compared with the control group.Cell proliferation was became slow obviously and cell apoptosis was accelerated.CONCLUSIONS:Those findings suggested that the hammerhead ribozyme targeting the hTR template can inhibit telomerase activity of esophageal carcinoma in vitro and it will be a new therapeutic approach to esophageal carcinoma.
出处 《肿瘤防治杂志》 2004年第8期811-813,共3页 China Journal of Cancer Prevention and Treatment
关键词 核酶 端粒 末端转移酶 食管肿瘤 凋亡 ribozyme telomere,terminal transferase esophageal neoplasms apoptosis
  • 相关文献

参考文献11

二级参考文献49

  • 1[1]Irie A, Anderegg B, Kashani-Sabet M, et al.Therapeutic efficacy of an adenovirus-mediated anti-H-ras ribozyme in experimental bladder cancer[J].Antisense Nucleic Acid Drug Dev,1999,9(4):341-349.
  • 2[2]Tsuchida T, Kijima H, Hori S,et al.Adenovirus-mediated anti-K-ras ribozyme induces apoptosis and growth suppression of human pancreatic carcinoma[J].Cancer Gene Ther,2000,7(3):373-383.
  • 3[3]Kijima H, Scanlon KJ. Ribozyme as an approach for growth suppression of human pancreatic cancer[J]. Mol Biotechnol,2000,14(1):59-72.
  • 4[4]Zhang YA, Nemunaitis J, Tong AW. Generation of a ribozyme-adenoviral vector against K-ras mutant human lung cancer cells[J].Mol Biotechnol,2000,15(1):39-49.
  • 5[5]Dorai T, Olsson CA, Katz AE,et al.Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer[J].Prostate,1997,32(4):246-58.
  • 6[6]Gibson SA, Pellenz C, Hutchison RE,et al.Induction of apoptosis in oral cancer cells by an anti-bcl-2 ribozyme delivered by an adenovirus vector[J].Clin Cancer Res,2000,6(1):213-222.
  • 7[7]Cheng J, Luo J, Zhang X, et al.Inhibition of cell proliferation in HCC-9204 hepatoma cells by a c-myc specific ribozyme[J].Cancer Gene Ther,2000,7(3): 407-412.
  • 8[8]Ke LD, Fueyo J, Chen X, et al.A novel approach to glioma gene therapy: down-regulation of the vascular endothelial growth factor in glioma cells using ribozymes[J].Int J Oncol,1998, 12(6):1 391-1 396.
  • 9[9]Morino F,Tokunage T,Tsucheda T,et al.Hammerhead ribozyme specifically inhibits vascular endothelial growth factor gene expression in a human hepatocellular carcinoma cell line[J].Int J Oncol,2000,17(3):495-499.
  • 10[10]Yokoyama Y,Takahashi Y,Shinohara A, et al.Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells[J].Cancer Res,1998,58(23): 5 406-5 410.

共引文献15

同被引文献10

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部